John Knoedler, MD
Urology · Hershey, PANPI 1578794459
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,550 of the $5,276 with a category attached, or 86.2%. Boston Scientific accounts for 94.7% of it on its own, with 3 other manufacturers making up the rest.
Across 9 payments — averaging $586.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Richard Wolf Medical Instruments Corp.$146
- Photocure Inc$92
- Astellas Pharma US Inc$42
Across 10 payments — averaging $5359.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$53K
- Urogen Pharma, Inc.$352
What the payments were for
- Consulting fees$4,55086%
- Travel & lodging$2525%
- Food & beverage$4749%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $4,997 |
| Richard Wolf Medical Instruments Corp. | 1 | $146 |
| Photocure Inc | 2 | $92 |
| Astellas Pharma US Inc | 1 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,276 in reported general payments places this provider in the 70th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 43 | $7,396 |
| Finasteride | 73 | $546 |
| Tamsulosin Hcl | 49 | $526 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $348 |
Paid to pharmacies, not to this prescriber.
Other urology in Hershey
- Susan MacdonaldHershey$40K
- John AndersonBethlehem$2.1M
- Demetrius BagleyPhiladelphia$739K
- Paul SieberLancaster$631K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Anthony DimatteoButler$189K
- Angelo BaccalaAllentown$166K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.